16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of Exelon capsule at maximal tolerated dose in mild to moderate
Chinese AD patients via dosage titration from 3mg/d to 12mg/d in a 16 weeks duration